D. Sambiasi

447 total citations
19 papers, 358 citations indexed

About

D. Sambiasi is a scholar working on Oncology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, D. Sambiasi has authored 19 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Genetics and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in D. Sambiasi's work include BRCA gene mutations in cancer (6 papers), Cancer Treatment and Pharmacology (6 papers) and Ovarian cancer diagnosis and treatment (3 papers). D. Sambiasi is often cited by papers focused on BRCA gene mutations in cancer (6 papers), Cancer Treatment and Pharmacology (6 papers) and Ovarian cancer diagnosis and treatment (3 papers). D. Sambiasi collaborates with scholars based in Italy, United States and Lebanon. D. Sambiasi's co-authors include Agnese Latorre, Michele Guida, E. Crucitta, M. De Lena, Annamaria Catino, Antonella Mazzei, Vito Lorusso, Giuseppe Fanizza, G Gargano and Stefania Tommasi and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

D. Sambiasi

19 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D. Sambiasi Italy	9	156	146	117	58	38	19	358
Krista Menard United States	6	188 1.2×	168 1.2×	90 0.8×	22 0.4×	12 0.3×	9	373
Xiangyun Zong China	10	252 1.6×	133 0.9×	201 1.7×	11 0.2×	32 0.8×	35	449
Shinji Oie Japan	12	315 2.0×	140 1.0×	88 0.8×	60 1.0×	32 0.8×	22	515
Seog-Nyeon Bae South Korea	8	155 1.0×	151 1.0×	116 1.0×	27 0.5×	64 1.7×	10	499
Gianmarco Motta Italy	9	194 1.2×	127 0.9×	80 0.7×	29 0.5×	32 0.8×	18	395
S E Holwell United Kingdom	7	233 1.5×	132 0.9×	99 0.8×	85 1.5×	22 0.6×	7	400
James Zweibel United States	8	258 1.7×	123 0.8×	70 0.6×	26 0.4×	30 0.8×	10	370
Branko Perunović United Kingdom	9	225 1.4×	60 0.4×	127 1.1×	51 0.9×	17 0.4×	15	343
Nicoletta Chicchinelli Italy	9	184 1.2×	184 1.3×	192 1.6×	18 0.3×	10 0.3×	12	453
Mario Brandi Italy	9	74 0.5×	192 1.3×	133 1.1×	6 0.1×	19 0.5×	30	299

Countries citing papers authored by D. Sambiasi

Since Specialization

Citations

This map shows the geographic impact of D. Sambiasi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Sambiasi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Sambiasi more than expected).

Fields of papers citing papers by D. Sambiasi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Sambiasi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Sambiasi. The network helps show where D. Sambiasi may publish in the future.

Co-authorship network of co-authors of D. Sambiasi

This figure shows the co-authorship network connecting the top 25 collaborators of D. Sambiasi. A scholar is included among the top collaborators of D. Sambiasi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Sambiasi. D. Sambiasi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Digennaro, Maria, D. Sambiasi, Stefania Tommasi, et al.. (2017). Hereditary and non-hereditary branches of family eligible for BRCA test: cancers in other sites. Hereditary Cancer in Clinical Practice. 15(1). 7–7. 15 indexed citations

Summa, Simona De, Francesca Graziano, Brunella Pilato, et al.. (2017). Six low-penetrance SNPs for the estimation of breast cancer heritability: A family-based study in Caucasian Italian patients. Oncology Letters. 14(4). 4384–4390. 2 indexed citations

Sambiasi, D., Simona De Summa, Maria Digennaro, et al.. (2017). Adipokines in hereditary breast cancer patients and healthy relatives. Oncotarget. 8(60). 101255–101261. 5 indexed citations

Schirosi, Laura, Simona De Summa, Stefania Tommasi, et al.. (2015). Immunoprofile from tissue microarrays to stratify familial breast cancer patients. Oncotarget. 6(29). 27865–27879. 5 indexed citations

Summa, Simona De, R. Pinto, Brunella Pilato, et al.. (2014). Expression of base excision repair key factors and miR17 in familial and sporadic breast cancer. Cell Death and Disease. 5(2). e1076–e1076. 19 indexed citations

Sambiasi, D., Brunella Pilato, Stefania Tommasi, et al.. (2013). BRCA1/2 and clinical outcome in a monoinstitutional cohort of women with hereditary breast cancer. Oncology Reports. 31(1). 365–369. 7 indexed citations

Summa, Simona De, R. Pinto, D. Sambiasi, et al.. (2013). BRCAness: a deeper insight into basal-like breast tumors. Annals of Oncology. 24. viii13–viii21. 48 indexed citations

Pilato, Brunella, Simona De Summa, Katia Danza, et al.. (2013). Genetic risk transmission in a family affected by familial breast cancer. Journal of Human Genetics. 59(1). 51–53. 4 indexed citations

Basso, Umberto, Claudio Bassi, Cristina Falci, et al.. (2008). Does multidimensional geriatric assessment influence the prescription of adjuvant chemotherapy to elderly women with early breast cancer in a multivariate model?. Journal of Clinical Oncology. 26(15_suppl). 20541–20541. 1 indexed citations

10.

Lorusso, Vito, Massimiliano Spada, A. Misino, et al.. (2006). Oral vinorelbine plus capecitabine (oral vincap) combination in patients with advanced breast cancer (ABC). A phase II study of the GOIM (Gruppo Oncologico dell'Italia Meridionale). Annals of Oncology. 17. vii15–vii17. 27 indexed citations

11.

Lorusso, Vito, Massimiliano Spada, A. Misino, et al.. (2006). Oral vinorelbine plus capecitabine (oral vincap) combination in patients with advanced breast cancer (ABC). Journal of Clinical Oncology. 24(18_suppl). 10673–10673. 12 indexed citations

12.

Portalone, L, et al.. (2005). Epirubicin and Gemcitabine as First-Line Treatment in Malignant Pleural Mesothelioma. Tumori Journal. 91(1). 15–18. 9 indexed citations

13.

Lorusso, Vito, E. Crucitta, Nicola Silvestris, et al.. (2003). Phase I/II study of gemcitabine plus mitoxantrone as salvage chemotherapy in metastatic breast cancer. British Journal of Cancer. 88(4). 491–495. 9 indexed citations

14.

Catino, Annamaria, et al.. (2003). Amifostine as chemoprotectant in metastatic breast cancer patients treated with doxorubicin. Oncology Reports. 10(1). 163–7. 5 indexed citations

15.

Lorusso, Vito, E. Crucitta, N. Panza, et al.. (2002). Phase I/II study of paclitaxel, gemcitabine and vinorelbine as first-line chemotherapy of non-small-cell lung cancer. Annals of Oncology. 13(12). 1862–1867. 4 indexed citations

16.

Latorre, Agnese, M. De Lena, Annamaria Catino, et al.. (2002). Epithelial ovarian cancer: Second and third line chemotherapy (Review). International Journal of Oncology. 21(1). 179–86. 27 indexed citations

17.

Lena, M. De, Vito Lorusso, Agnese Latorre, et al.. (2001). Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II study. European Journal of Cancer. 37(3). 364–368. 150 indexed citations

18.

Crucitta, E., et al.. (2000). New aromatase inhibitors in the treatment of advanced breast cancer.. International Journal of Oncology. 17(5). 1037–41. 8 indexed citations

19.

Catino, Annamaria, et al.. (1999). Phase I/II study of gemcitabine plus mitoxantrone in advanced breast cancer (ABC). European Journal of Cancer. 35. S317–S317. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact